Emergence, Development, and Future of Cardio-Oncology in China
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine
Reference32 articles.
1. 2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The task force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC);Zamorano;Eur Heart J,2016
2. Declining death rates reflect progress against cancer;Jemal;PLoS One,2010
3. Improved estimates of cancer-specific survival rates from population-based data;Howlader;J Natl Cancer Inst,2010
4. Breast cancer survivorship: A comprehensive review of long-term medical issues and lifestyle recommendations;Bodai;Perm J,2015
5. Cancer treatment and survivorship statistics, 2012;Siegel;CA Cancer J Clin,2012
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cardio-oncology: Examination of progress in China from an oncologist's perspective;Asia-Pacific Journal of Oncology Nursing;2024-06
2. Cardio-oncology in China;Current Treatment Options in Oncology;2023-08-11
3. Advancing Cardio-Oncology in Asia;Korean Circulation Journal;2023
4. Working Together to Advance Cardio-Oncology in China;JACC: CardioOncology;2020-03
5. Emergence, development, and future of cardio-oncology in China;Chinese Medical Journal;2019-03-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3